USANA Health Sciences ROE 2012-2026 | USNA

Current and historical return on equity (ROE) values for USANA Health Sciences (USNA) over the last 10 years. Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
USANA Health Sciences ROE - Return on Equity Historical Data
Date TTM Net Income Shareholder's Equity Return on Equity
2026-06-30 $-0.02B $0.53B -4.13%
2026-03-31 $0.01B $0.53B 1.69%
2025-12-31 $0.01B $0.53B 1.89%
2025-09-30 $0.02B $0.53B 3.02%
2025-06-30 $0.03B $0.53B 6.40%
2025-03-31 $0.03B $0.53B 6.45%
2024-12-31 $0.04B $0.52B 8.09%
2024-09-30 $0.06B $0.51B 10.77%
2024-06-30 $0.06B $0.50B 11.12%
2024-03-31 $0.06B $0.48B 12.81%
2023-12-31 $0.06B $0.47B 13.33%
2023-09-30 $0.06B $0.46B 12.91%
2023-06-30 $0.06B $0.44B 14.25%
2023-03-31 $0.07B $0.43B 15.26%
2022-12-31 $0.07B $0.41B 16.84%
2022-09-30 $0.08B $0.40B 19.00%
2022-06-30 $0.09B $0.40B 22.17%
2022-03-31 $0.11B $0.40B 26.70%
2021-12-31 $0.12B $0.40B 28.71%
2021-09-30 $0.14B $0.42B 32.71%
2021-06-30 $0.14B $0.41B 33.88%
2021-03-31 $0.13B $0.40B 32.85%
2020-12-31 $0.13B $0.38B 33.64%
2020-09-30 $0.12B $0.35B 33.24%
2020-06-30 $0.11B $0.33B 33.01%
2020-03-31 $0.10B $0.34B 30.12%
2019-12-31 $0.10B $0.36B 27.76%
2019-09-30 $0.10B $0.37B 27.30%
2019-06-30 $0.11B $0.40B 26.97%
2019-03-31 $0.12B $0.41B 29.39%
2018-12-31 $0.13B $0.41B 30.42%
2018-09-30 $0.09B $0.41B 21.61%
2018-06-30 $0.08B $0.39B 20.82%
2018-03-31 $0.07B $0.38B 18.54%
2017-12-31 $0.06B $0.37B 16.95%
2017-09-30 $0.09B $0.36B 25.26%
2017-06-30 $0.10B $0.34B 28.03%
2017-03-31 $0.10B $0.32B 31.40%
2016-12-31 $0.10B $0.29B 34.72%
2016-09-30 $0.10B $0.28B 36.82%
2016-06-30 $0.10B $0.28B 35.22%
2016-03-31 $0.10B $0.28B 34.52%
2015-12-31 $0.10B $0.28B 33.57%
2015-09-30 $0.09B $0.27B 34.04%
2015-06-30 $0.09B $0.24B 35.16%
2015-03-31 $0.08B $0.23B 33.76%
2014-12-31 $0.08B $0.24B 31.57%
2014-09-30 $0.08B $0.25B 30.18%
2014-06-30 $0.07B $0.26B 28.24%
2014-03-31 $0.08B $0.25B 31.39%
2013-12-31 $0.08B $0.23B 35.03%
2013-09-30 $0.08B $0.21B 37.24%
2013-06-30 $0.08B $0.20B 39.24%
2013-03-31 $0.07B $0.19B 37.09%
2012-12-31 $0.07B $0.19B 34.83%
2012-09-30 $0.06B $0.19B 32.71%
2012-06-30 $0.06B $0.18B 31.64%
2012-03-31 $0.05B $0.17B 31.45%
2011-12-31 $0.05B $0.16B 31.50%
2011-09-30 $0.05B $0.15B 32.24%
2011-06-30 $0.05B $0.15B 34.54%
2011-03-31 $0.05B $0.13B 35.61%
2010-12-31 $0.05B $0.12B 39.83%
2010-09-30 $0.04B $0.10B 45.24%
2010-06-30 $0.04B $0.08B 48.45%
2010-03-31 $0.04B $0.07B 53.62%
2009-12-31 $0.03B $0.06B 58.87%
2009-09-30 $0.03B $0.05B 59.26%
2009-06-30 $0.03B $0.04B 66.27%
2009-03-31 $0.03B $0.04B 65.54%
2008-12-31 $0.03B $0.05B 62.37%
2008-09-30 $0.04B $0.05B 77.01%
2008-06-30 $0.04B $0.04B 92.31%
2008-03-31 $0.04B $0.03B 128.00%
2007-12-31 $0.05B $0.04B 122.45%
2007-09-30 $0.04B $0.04B 101.15%
2007-06-30 $0.04B $0.05B 85.57%
2007-03-31 $0.04B $0.06B 75.34%
2006-12-31 $0.04B $0.05B 76.92%
2006-09-30 $0.04B $0.05B 82.47%
2006-06-30 $0.04B $0.05B 76.56%
2006-03-31 $0.04B $0.06B 71.11%
2005-12-31 $0.04B $0.06B 68.42%
2005-09-30 $0.04B $0.06B 66.09%
2005-06-30 $0.04B $0.05B 68.25%
2005-03-31 $0.03B $0.05B 65.67%
2004-12-31 $0.03B $0.05B 65.22%
2004-09-30 $0.03B $0.05B 62.22%
2004-06-30 $0.03B $0.04B 63.41%
2004-03-31 $0.02B $0.04B 61.33%
2003-12-31 $0.02B $0.03B 64.12%
2003-09-30 $0.02B $0.03B 64.76%
2003-06-30 $0.01B $0.02B 57.78%
2003-03-31 $0.01B $0.02B 57.89%
2002-12-31 $0.01B $0.02B 47.06%
2002-09-30 $0.01B $0.02B 36.92%
2002-06-30 $0.01B $0.02B 32.26%
2002-03-31 $0.00B $0.02B 20.34%
2001-12-31 $0.00B $0.01B 14.29%
2001-09-30 $0.00B $0.01B 14.81%
2001-06-30 $0.00B $0.01B 7.69%
2001-03-31 $0.00B $0.01B 8.00%
2000-12-31 $0.00B $0.01B 16.33%
2000-09-30 $0.00B $0.01B 24.49%
2000-06-30 $0.00B $0.01B 16.67%
2000-03-31 $0.00B $0.02B 23.88%
1999-12-31 $0.01B $0.02B 22.73%
1999-09-30 $0.01B $0.03B 22.64%
1999-06-30 $0.01B $0.03B 32.79%
1999-03-31 $0.01B $0.03B 34.78%
1998-12-31 $0.01B $0.03B 38.83%
1998-09-30 $0.01B $0.02B 39.56%
1998-06-30 $0.01B $0.02B 39.51%
1998-03-31 $0.01B $0.02B 50.00%
1997-12-31 $0.01B $0.01B 56.00%
1997-09-30 $0.01B $0.01B 63.16%
1997-06-30 $0.01B $0.01B 74.07%
1997-03-31 $0.00B $0.01B 61.54%
1996-12-31 $0.00B $0.01B 64.00%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.275B $0.925B
USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $68.396B 22.59
Takeda Pharmaceutical (TAK) Japan $59.919B 11.13
UCB SA (UCBJY) Belgium $45.739B 0.00
Otsuka Holdings, - (OTSKY) Japan $39.680B 14.84
BeOne Medicines - (ONC) Switzerland $38.041B 61.00
Sandoz Group AG (SDZNY) Switzerland $35.464B 0.00
Daiichi Sankyo, - (DSNKY) Japan $34.072B 21.27
Zoetis (ZTS) United States $30.343B 11.16
Astellas Pharma (ALPMY) Japan $26.892B 8.90
United Therapeutics (UTHR) United States $21.460B 17.90
Merck (MKKGY) Germany $19.487B 15.54
Shionogi (SGIOY) Japan $15.947B 9.37
IPSEN (IPSEY) France $15.395B 0.00
Neurocrine Biosciences (NBIX) United States $15.249B 20.72
Summit Therapeutics (SMMT) United States $13.881B 0.00
Orion OYJ (ORINY) Finland $12.984B 18.93
Madrigal Pharmaceuticals (MDGL) United States $12.089B 0.00
Corcept Therapeutics (CORT) United States $11.979B 263.86
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $11.965B 15.26
Crinetics Pharmaceuticals (CRNX) United States $9.013B 0.00
Eisai (ESAIY) $8.924B 0.00
Ionis Pharmaceuticals (IONS) United States $7.852B 0.00
Ono Pharmaceutical (OPHLF) Japan $7.049B 13.27
Stevanato Group S.p.A (STVN) Italy $6.523B 32.64
Centessa Pharmaceuticals (CNTA) United Kingdom $6.267B 0.00
Oruka Therapeutics (ORKA) United States $6.105B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $5.317B 19.36
Grifols, S.A (GRFS) Spain $5.009B 0.00
Definium Therapeutics (DFTX) United States $4.947B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.923B 0.00
Relay Therapeutics (RLAY) United States $4.157B 0.00
Indivior Pharmaceuticals (INDV) United States $4.039B 9.38
Enliven Therapeutics (ELVN) United States $3.910B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.855B 11.93
Amylyx Pharmaceuticals (AMLX) United States $3.694B 0.00
Dyne Therapeutics (DYN) United States $3.343B 0.00
Hypermarcas (HYPMY) Brazil $3.203B 9.10
Soleno Therapeutics (SLNO) United States $2.717B 228.83
NewAmsterdam Pharma (NAMS) Netherlands $2.529B 0.00
Guardian Pharmacy Services (GRDN) United States $2.390B 45.28
Nektar Therapeutics (NKTR) United States $2.275B 0.00
Ocular Therapeutix (OCUL) United States $2.238B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $2.146B 15.81
Avadel Pharmaceuticals (AVDL) Ireland $2.113B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.085B 5.63
Xencor (XNCR) United States $1.766B 0.00
KARDIGAN INC (KARD) United States $1.735B 0.00
Xeris Biopharma Holdings (XERS) United States $1.366B 107.00
Harrow (HROW) United States $1.269B 0.00
Seaport Therapeutics (SPTX) United States $1.229B 0.00
Aktis Oncology (AKTS) United States $1.204B 0.00
Cronos Group (CRON) Canada $1.179B 29.09
Bioventus (BVS) United States $1.093B 17.10
Savara (SVRA) United States $1.081B 0.00
KalVista Pharmaceuticals (KALV) United States $0.993B 0.00
Cybin (HELP) Canada $0.992B 0.00
Theravance Biopharma (TBPH) United States $0.885B 0.00
Avalo Therapeutics (AVTX) United States $0.862B 0.00
Ardelyx (ARDX) United States $0.847B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.821B 11.32
Esperion Therapeutics (ESPR) United States $0.819B 0.00
Aclaris Therapeutics (ACRS) United States $0.773B 0.00
Achieve Life Sciences (ACHV) Canada $0.753B 0.00
4D Molecular Therapeutics (FDMT) United States $0.753B 0.00
Silence Therapeutics (SLN) United Kingdom $0.750B 0.00
Apnimed (APMD) $0.711B 0.00
Collegium Pharmaceutical (COLL) United States $0.711B 3.13
Zevra Therapeutics (ZVRA) United States $0.692B 7.37
Ironwood Pharmaceuticals (IRWD) United States $0.671B 5.21
OmniAb (OABI) United States $0.630B 0.00
Altimmune (ALT) United States $0.628B 0.00
Aquestive Therapeutics (AQST) United States $0.604B 0.00
Evotec AG (EVO) Germany $0.580B 0.00
ProKidney (PROK) United States $0.526B 0.00
Indaptus Therapeutics (INDP) United States $0.485B 0.00
Relmada Therapeutics (RLMD) United States $0.474B 0.00
ARS Pharmaceuticals (SPRY) United States $0.423B 0.00
Larimar Therapeutics (LRMR) United States $0.406B 0.00
Prelude Therapeutics (PRLD) United States $0.361B 0.00
Century Therapeutics (IPSC) United States $0.359B 0.00
Lexeo Therapeutics (LXEO) United States $0.339B 0.00
Inhibikase Therapeutics (IKT) United States $0.322B 0.00
Avita Medical (RCEL) United States $0.314B 0.00
Pyxis Oncology (PYXS) United States $0.278B 0.00
Elite Pharmaceuticals (ELTP) United States $0.268B 12.44
Lyell Immunopharma (LYEL) United States $0.267B 0.00
Akebia Therapeutics (AKBA) United States $0.250B 0.00
Galectin Therapeutics (GALT) United States $0.246B 0.00
Nature's Sunshine Products (NATR) United States $0.230B 11.17
AleAnna (ANNA) United States $0.226B 17.84
Protara Therapeutics (TARA) United States $0.222B 0.00
Cardiol Therapeutics (CRDL) Canada $0.215B 0.00
Siga Technologies (SIGA) United States $0.214B 0.00
Journey Medical (DERM) United States $0.208B 0.00
Profound Medical (PROF) Canada $0.208B 0.00
Korro Bio (KRRO) United States $0.207B 0.00
Surrozen (SRZN) United States $0.206B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.199B 0.00
Organogenesis (ORGO) United States $0.188B 0.00
Minerva Neurosciences (NERV) United States $0.183B 0.00
MediWound (MDWD) Israel $0.173B 0.00
Atrium Therapeutics (RNA) United States $0.173B 0.00
NRx Pharmaceuticals (NRXP) United States $0.147B 0.00
Innate Pharma SA (IPHYF) France $0.138B 0.00
Unicycive Therapeutics (UNCY) United States $0.131B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.129B 0.00
VAXART, INC (VXRT) United States $0.117B 3.00
Assertio Holdings (ASRT) United States $0.116B 0.00
Rafael Holdings (RFL) United States $0.111B 0.00
Vivani Medical (VANI) United States $0.111B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.103B 0.00
Cassava Sciences (SAVA) United States $0.101B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.099B 0.00
PolyPid (PYPD) Israel $0.098B 0.00
HST Global (HSTC) United States $0.092B 0.00
ElectroCore (ECOR) United States $0.091B 0.00
Fractyl Health (GUTS) United States $0.090B 0.00
Nutriband (NTRB) United States $0.083B 0.00
Aldeyra Therapeutics (ALDX) United States $0.083B 0.00
Telomir Pharmaceuticals (TELO) United States $0.080B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.079B 0.00
Acrivon Therapeutics (ACRV) United States $0.078B 0.00
Gain Therapeutics (GANX) United States $0.075B 0.00
PMV Pharmaceuticals (PMVP) United States $0.073B 0.00
Champions Oncology (CSBR) United States $0.066B 0.00
Talphera (TLPH) United States $0.062B 0.00
Nuo Therapeutics (AURX) $0.061B 0.00
Heron Therapeutics (HRTX) United States $0.060B 0.00
Dominari Holdings (DOMH) United States $0.053B 0.00
Veraxa Biotech AG (VRXA) United States $0.048B 0.00
SCYNEXIS (SCYX) United States $0.044B 0.00
Incannex Healthcare (IXHL) Australia $0.041B 0.00
FibroGen (FGEN) United States $0.039B 0.00
Lite Strategy (LITS) United States $0.037B 0.00
Mural Oncology (MURA) Ireland $0.035B 0.00
Karyopharm Therapeutics (KPTI) United States $0.035B 0.00
Context Therapeutics (CNTX) United States $0.033B 0.00
Optimi Health (OPTH) Canada $0.029B 0.00
Cosmos Health (COSM) United States $0.028B 0.00
TransCode Therapeutics (RNAZ) United States $0.027B 0.00
Plus Therapeutics (PSTV) United States $0.027B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Universe Pharmaceuticals INC (UPC) China $0.022B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.020B 0.00
VYNE Therapeutics (VYNE) United States $0.019B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Klotho Neurosciences (KLTO) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Enlivex (ENLV) Israel $0.015B 0.00
Citius Pharmaceuticals (CTXR) United States $0.015B 0.00
BioVie (BIVI) United States $0.015B 0.00
Iterum Therapeutics (ITRM) Ireland $0.015B 0.00
Vyome Holdings (HIND) United States $0.014B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.014B 0.00
Tempest Therapeutics (TPST) United States $0.012B 0.00
Natural Alternatives (NAII) United States $0.012B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.012B 0.00
CASI Pharmaceuticals (CASI) China $0.010B 0.00
Xenetic Biosciences (XBIO) United States $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Wellgistics Health (WGRX) United States $0.009B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Inotiv (NOTV) United States $0.008B 0.00
Biomerica (BMRA) United States $0.007B 0.00
Curanex Pharmaceuticals Inc (CURX) United States $0.007B 0.00
Ernexa Therapeutics (ERNA) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.005B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.005B 0.00
Liminatus Pharma (LIMN) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
Niki BioSolutions (NIKI) United Kingdom $0.004B 0.00
Nuvilex (PMCB) United States $0.004B 0.00
Addex Therapeutics (ADXN) Switzerland $0.004B 0.00
Galmed Pharmaceuticals (EOCN) Israel $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Jupiter Neurosciences (JUNS) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Vivos Therapeutics (VVOS) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Jaguar Animal Health (JAGX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Clearmind Medicine (CMND) Canada $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
CDT Equity (CDT) United States $0.000B 0.00
Emisphere Technologies (EMIS) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00